ARCHIVES

“Recalcitrant” Cancers? Committee Rewrite Of Pancreatic Bill Raises New Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 34 | September 14, 2012

Download PDF Visit The Full Archive

Related Articles

New Cooperative Group Funded

September 30, 1977

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

No Constitutional Right To Experimental Drugs, Appeals Court Rules Against Abigail Alliance.

August 10, 2007

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011

In Brief: John Campbell, Nida Contracts Chief, New Head Of NCI Contracts Branch; PHS Honors Seven At NCI

June 10, 1983

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

February 28, 2014